Schedule 13G ownership disclosure
KARYOPHARM THERAPEUTICS INC
Security class unavailable · CUSIP: 48576U106
Event date: 2016-09-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,258,985
- Percent of class
- 11.8300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-16-001225
- Form type
- SC 13G
- Filer
- Karyopharm Therapeutics Inc.
- CIK
- CIK 1503802
- Filed
- Oct 11, 2016
- Reporting period
- Sep 30, 2016
- Description
- Schedule 13G beneficial ownership